GSK_ Annual_Report_2021-22

Notes to the Consolidated Financial Statements for the year ended March 31, 2022 251 (ii) Other related parties in the GlaxoSmithKline (GSK) Group where common control exists and with whom the Group had transactions during the year: GlaxoSmithKline Asia Private Limited, India GlaxoSmithKline Biologicals S.A., Belgium GlaxoSmithKline Pharmaceuticals S.A., Belgium* GlaxoSmithKline Services Unlimited, U.K. Glaxo Operations UK Limited, U.K. GlaxoSmithKline Pharmaceutical Sdn Bhd, Malaysia* GlaxoSmithKline Export Limited, U.K. SmithKline Beecham Pharmaceuticals , U.S.A.* GlaxoSmithKline Research & Development Ltd, U.K. GlaxoSmithKline LLC, U.S.A. GlaxoSmithKline Trading Services Limited, Ireland GlaxoSmithKline South Africa (Pty) Ltd. South Africa* GlaxoSmithkline Pharma India Pvt Ltd. GSK India Global Services Private Limited GlaxoSmithKline Pharmaceutical Ltd., Sri Lanka US GMS Financial Services, U.S.A.* GlaxoSmithKline (Thailand) Ltd. GSK Consumer Healthcare (UK) Trading Limited GSK Consumer Healthcare Pte Ltd., Singapore PT Smithkline Beecham Pharmaceuticals Ltd., Indonesia PT Glaxo Wellcome Indonesia * no transactions during the year (iii) Directors and members of GSK India Leadership Team : Directors: GSK India Leadership Team: Mr. J. Chandy # (w.e.f. April 1, 2022) Mr. A. Nadkarni Ms. P. Thakur # (upto March 31, 2022) Mr. R. D'souza Mr. S. Venkatesh # (w.e.f. April 1, 2020) Mr. S. Dheri Mr. M. Dawson (w.e.f. Janaury 28, 2021) Ms. S. Choudhary Ms. S. Maheshwari (w.e.f. May 18, 2020) Ms. P. Hingorani Mr. N. Kaviratne Dr. R. Hegde (w.e.f. September 02, 2021) Mr. P. Bhide Mr. R. Manchanda (w.e.f. May 18, 2021) Ms. R. S. Karnad Mr. S. Mitra (w.e.f. April 01, 2021) Mr. A. N. Roy Mr. B. Kotak (upto June 30, 2021) Mr. D. Sundaram Mr. A. Iyer (upto March 31, 2021) Mr. S. Williams Mr. S. Balasubramanian